Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP2A13 | Q16696 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26620491 | 0.90 | PTGDR2 (0.46) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL26636472 | 0.88 | PTGDR2 (0.46) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL26636396 | 0.87 | PTGDR2 (0.45) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL26636508 | 0.85 | PTGDR2 (0.44) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL26620168 | 0.84 | PTGDR2 (0.47) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL27010431 | 0.84 | PTGDR2 (0.43) | PTGDR2TSHRNPC1ALDH1A1L3MBTL1 | |
| SCHEMBL24316060 | 0.82 | PTGDR2 (0.48) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL27010304 | 0.81 | PTGDR2 (0.45) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL26620496 | 0.81 | PTGDR2 (0.46) | PTGDR2TSHRNPC1ALDH1A1KMT2A | |
| SCHEMBL24317323 | 0.81 | NPC1 (0.43) | PTGDR2TSHRNPC1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081925-A1 | TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 | C4 THERAPEUTICS, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| US-9585884-B2 | Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2017-03-07 | — | — | US | disclosed |